BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27902324)

  • 21. Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
    Halder S; Murakami M; Verma SC; Kumar P; Yi F; Robertson ES
    PLoS One; 2009 Sep; 4(9):e7214. PubMed ID: 19784370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.
    Katsumura KR; Maruo S; Takada K
    J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBNA2 and Its Coactivator EBNA-LP.
    Kempkes B; Ling PD
    Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.
    Bernasconi M; Ueda S; Krukowski P; Bornhauser BC; Ladell K; Dorner M; Sigrist JA; Campidelli C; Aslandogmus R; Alessi D; Berger C; Pileri SA; Speck RF; Nadal D
    Int J Cancer; 2013 Nov; 133(10):2341-50. PubMed ID: 23640782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRLF1-dependent viral and cellular transcriptomes and transcriptional regulation during EBV primary infection in B lymphoma cells.
    Long X; Yang Z; Li Y; Sun Q; Li X; Kuang E
    Genomics; 2021 Jul; 113(4):2591-2604. PubMed ID: 34087421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of toll-like receptor stimulation on expression of EBV lytic genes.
    Siennicka J; Trzcińska A; Cześcik A; Dunal-Szczepaniak M; Lagosz B
    Pol J Microbiol; 2013; 62(3):237-42. PubMed ID: 24459828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.
    Hutt-Fletcher LM
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rta is an Epstein-Barr virus tegument protein that improves the stability of capsid protein BORF1.
    Huang HH; Wang WH; Feng TH; Chang LK
    Biochem Biophys Res Commun; 2020 Mar; 523(3):773-779. PubMed ID: 31948747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel expression and regulation of TIMP-1 in Epstein Barr virus-infected cells and its impact on cell survival.
    Lin SJ; Wu SW; Chou YC; Lin JH; Huang YC; Chen MR; Ma N; Tsai CH
    Virology; 2015 Jul; 481():24-33. PubMed ID: 25765004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
    Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
    J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNAs in Epstein-Barr virions control early steps of infection.
    Jochum S; Ruiss R; Moosmann A; Hammerschmidt W; Zeidler R
    Proc Natl Acad Sci U S A; 2012 May; 109(21):E1396-404. PubMed ID: 22543160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus Strain Variation.
    Farrell PJ
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):45-69. PubMed ID: 26424643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.
    Craig FE; Johnson LR; Harvey SA; Nalesnik MA; Luo JH; Bhattacharya SD; Swerdlow SH
    Diagn Mol Pathol; 2007 Sep; 16(3):158-68. PubMed ID: 17721324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
    Wu H; Li T; Zeng M; Peng T
    Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of global methylation using a Zta-expressing nasopharyngeal carcinoma cell line.
    Chen YF; Tung CL; Chang Y; Hsiao WC; Su LJ; Sun HS
    Genomics; 2011 Apr; 97(4):205-13. PubMed ID: 21195163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.